News
NIKA
0.250
NaN%
--
Weekly Report: what happened at NIKA last week (0908-0912)?
Weekly Report · 09/15 12:17
Weekly Report: what happened at NIKA last week (0901-0905)?
Weekly Report · 09/08 12:20
Weekly Report: what happened at NIKA last week (0825-0829)?
Weekly Report · 09/01 12:12
Weekly Report: what happened at NIKA last week (0818-0822)?
Weekly Report · 08/25 12:29
Weekly Report: what happened at NIKA last week (0811-0815)?
Weekly Report · 08/18 12:17
Weekly Report: what happened at NIKA last week (0804-0808)?
Weekly Report · 08/11 12:28
Weekly Report: what happened at NIKA last week (0728-0801)?
Weekly Report · 08/04 12:32
Weekly Report: what happened at NIKA last week (0721-0725)?
Weekly Report · 07/28 12:32
Weekly Report: what happened at NIKA last week (0714-0718)?
Weekly Report · 07/21 12:18
Weekly Report: what happened at NIKA last week (0707-0711)?
Weekly Report · 07/14 12:32
Weekly Report: what happened at NIKA last week (0630-0704)?
Weekly Report · 07/07 12:19
Weekly Report: what happened at NIKA last week (0623-0627)?
Weekly Report · 06/30 12:28
Weekly Report: what happened at NIKA last week (0616-0620)?
Weekly Report · 06/23 12:17
Weekly Report: what happened at NIKA last week (0609-0613)?
Weekly Report · 06/16 12:27
Weekly Report: what happened at NIKA last week (0602-0606)?
Weekly Report · 06/09 12:29
Weekly Report: what happened at NIKA last week (0526-0530)?
Weekly Report · 06/02 12:43
Weekly Report: what happened at NIKA last week (0519-0523)?
Weekly Report · 05/26 12:41
Nika Pharmaceuticals markets analysis and €8.5B projected revenue
Seeking Alpha · 05/19 15:21
Weekly Report: what happened at NIKA last week (0512-0516)?
Weekly Report · 05/19 12:27
Weekly Report: what happened at NIKA last week (0505-0509)?
Weekly Report · 05/12 12:28
More
Webull provides a variety of real-time NIKA stock news. You can receive the latest news about Nika Pharmaceuticals through multiple platforms. This information may help you make smarter investment decisions.
About NIKA
Nika Pharmaceuticals, Inc. is engaged in the development and distribution of a variety of pharmaceutical products, including dietary supplements and antiviral drugs. It has the exclusive rights agreement for the production and distribution of two dietary supplements, namely Carotilen and Physiolong. Carotilen is a dietary supplement in the form of soft gelatin capsules that improves and regulates the metabolism of the epithelial cells and protects them from degenerative alterations. Physiolong is a dietary food supplement in the form of hard gelatin capsules, which serves as a general stimulant for those in a period of convalescence, as well as in situations of high mental and physical loads. It has an exclusive rights agreement for the production and distribution of Thymus Nuclear Glycoprotein (TNG). It also has the rights agreement for the production and sale of an additional six dietary supplements, such as Hypocholestin, Biodetoxin, Dry Boza, Fructin, Anthocylen C, and Silymaron.